Skip to main content
Premium Trial:

Request an Annual Quote

Vela Diagnostics Sentosa SQ HCV Genotyping Assay

Vela Diagnostics has launched a new version of its Sentosa SQ HCV Genotyping Assay with improved reporting and data-interpretation features. The test uses next-generation sequencing to detect HCV genotypes 1, 2, 3, 4, 5, and 6, and subtypes 1a and 1b, and to report HCV variants in clinically relevant regions of NS3, NS5A and NS5B genes to allow drug-resistance assessment. This assay offers an integrated solution from sample to result in approximately two days with hands-on time of less than 2.5 hours.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.